By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oncobiologics Inc.  

7 Clarke Drive

Cranbury  New Jersey  08512  U.S.A.
Phone: 609-619-3990 Fax: 609-619-3980



Company News
Oncobiologics Announces ONS-1045 (Avastin/bevacizumab biosimilar) Meets Primary And Secondary Endpoints In Phase 1 Clinical Trial 10/5/2015 6:14:12 AM
Oncobiologics Secures Financing From Sabby Management, LLC, To Advance BioSymphony Platform And Monoclonal Antibody Biosimilars Pipeline 9/29/2015 6:39:22 AM
Oncobiologics Appoints Lawrence A. Kenyon as Chief Financial Officer 9/16/2015 6:40:10 AM
Oncobiologics Secures $31 Million Financing 7/27/2015 5:56:21 AM
Oncobiologics Pushes Into Biosimilars Market with New Manufacturing Facility 5/4/2015 9:01:01 AM
Oncobiologics Inc. Announces Completion Of Clinical Dosing For bevacizumab (Avastin biosimilar) Candidate 4/15/2015 10:40:42 AM
Oncobiologics Inc. Announces ONS-3010 (Humira/Adalimumab Biosimilar) Meets Primary Endpoints In First Clinical Study 2/12/2015 7:32:10 AM
Oncobiologics Inc. Appoints Dr. Todd C. Brady To Its Board Of Directors 10/7/2014 9:44:41 AM
Strides Arcolab Limited Makes Strategic Investment In Oncobiologics Inc., USA 7/16/2014 10:02:19 AM
Liomont And Oncobiologics Inc. Partner To Launch Biosimilars In Mexico 6/26/2014 8:09:10 AM